Moreover, in patients with Stage III colorectal cancer, the levels of 20S proteasomes (more than two units) and MMP9+ subpopulations (less than 60%) in plasma exosomes are favorable prognostic factors for overall survival. The gene discussed is MMP9; the disease is colorectal cancer.